TriangleFOR PATIENTS · SOURCE READING
Targeted therapy
Source: Childhood Soft Tissue Sarcoma (PDQ®)–Patient Version, National Cancer Institute.
Source updated: May 9, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Context: Types of treatment for childhood soft tissue sarcoma
Targeted therapy uses drugs or other substances to block the action of specific enzymes, proteins, and other molecules involved in the growth and spread of cancer cells. Targeted therapies used to treat soft tissue sarcoma include:
Atezolizumab is used to treat children older than 2 years with alveolar soft part sarcoma that can't be removed with surgery or has spread to other places in the body.
Source links and citations
Larotrectinib is used to treat infantile fibrosarcoma.
Source links and citations
Sirolimus may be used to treat PEComas.
Source links and citations
Tazemetostat is used to treat epithelioid sarcoma.
Source links and citations
Learn more about Targeted Therapy to Treat Cancer.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice